• image.alt
  • With Mayo Clinic clinical neuropsychologist

    Glenn Smith, Ph.D.

    read biography
Please read: Important 2013 cancer research update from Dr. Michael Camilleri

Free

E-newsletter

Subscribe to Housecall

Our weekly general interest
e-newsletter keeps you up to date on a wide variety of health topics.

Sign up now

Question

Axona: Medical food to treat Alzheimer's

I've heard about an Alzheimer's supplement called Axona. What does it do, and can it really treat Alzheimer's?

Answer

Alzheimer's Caregiving

Subscribe to our Alzheimer's Caregiving e-newsletter to stay up to date on Alzheimer's topics.

Sign up now
from Glenn Smith, Ph.D.

Axona is a prescription dietary supplement that claims to target the nutritional needs of people with Alzheimer's disease. Alzheimer's is thought to hinder the brain's ability to break down glucose. According to Axona's marketing materials, the supplement provides an alternative energy source that the brain can use instead of glucose.

It's not clear what benefits, if any, Axona provides. A small study, funded by the manufacturers of the product, found that memory and cognition improved for people with mild to moderate Alzheimer's disease. However, more studies are needed to determine its safety and effectiveness.

Axona is marketed as a medical food. Medical foods are dietary supplements that help manage a disease or condition that causes nutritional deficiencies. The Alzheimer's Association, however, disputes the notion that Alzheimer's disease causes nutritional deficiencies and requires a medical food. Medical foods are given only under the supervision of a doctor. But the Food and Drug Administration doesn't approve medical foods, nor does it test medical foods for safety or effectiveness.

Until more is known, the Alzheimer's Association doesn't recommend the use of medical foods, including Axona, for the treatment of Alzheimer's disease.

Next question
Huperzine A: Can it treat Alzheimer's?
References
  1. Is it really approved? U.S. Food and Drug Administration. http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm153239.htm. Accessed May 30, 2011.
  2. Medical food. Alzheimer's Association. http://www.alz.org/national/documents/statements_medicalfoods.pdf. Accessed May 30, 2011.
  3. Koenigsberg RA, et al. Neuroimaging. In: Goetz CG. Textbook of Clinical Neurology. 3rd ed. Philadelphia, Pa.: Saunders Elsevier; 2007:437.
  4. Frequently asked questions. Accera Inc. http://about-axona.com/faq.html. Accessed May 30, 2011.
  5. Alternative treatments. Alzheimer's Association. http://www.alz.org/alzheimers_disease_alternative_treatments.asp#Caprylic_Acid. Accessed May 3, 2011.
  6. Howland RH. Drug therapies for cognitive impairment and dementia. Journal of Psychosocial Nursing and Mental Health Services. 2010;48:11.
  7. Roman MW. Axona (Accera Inc): A new medical food therapy for persons with Alzheimer's disease. Issues in Mental Health Nursing. 2010;31:435.
AN01992 Aug. 4, 2011

© 1998-2013 Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. A single copy of these materials may be reprinted for noncommercial personal use only. "Mayo," "Mayo Clinic," "MayoClinic.com," "EmbodyHealth," "Enhance your life," and the triple-shield Mayo Clinic logo are trademarks of Mayo Foundation for Medical Education and Research.

  • Reprints
  • Print
  • Share on:

  • Email

Advertisement


Text Size: smaller largerlarger